Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation
- 460 Downloads
Background There is a relative paucity of information to characterise potential changes in medication regimen complexity and prevalence of prescribing of potentially inappropriate medications after hospitalisation, both in Australia and elsewhere. Objective To evaluate medication regimen complexity and the prevalence of potentially inappropriate medications before and after admission to hospital. Setting General medical units of a tertiary care hospital in Australia. Methods Retrospective cohort study of patients aged 65 years and above. Medication complexity was measured by using the Medication Regimen Complexity Index (MRCI). Main outcome measure The primary outcome was the change in the Medication Regimen Complexity Index for all prescribed medications after hospitalization. Results A convenience sample of 100 patients was included in the study. There was a significant change in the mean medication complexity score (as measured using the MRCI), increasing from 29 at the time of admission to 32 at the time of discharge (p < 0.05). Factors such as baseline medication regimen complexity (pre-admission MRCI) and length of stay in the hospitals appear to influence the change in medication complexity. However, the proportion of patients prescribed at least one potentially inappropriate medicine (PIM) decreased significantly, from 52% pre-hospitalization to 42% at discharge (p = 0.04). Conclusions Relative to the time of admission, overall medication complexity increased and the proportion of patients who were prescribed PIMs decreased after hospitalisation.
KeywordsAustralia Beers criteria Medication regimen complexity index Potentially inappropriate medication
The authors would like to acknowledge the help of Winifred Greenshields, Associate Director of Pharmacy, Southern Adelaide Local Health Network, who assisted by facilitating data collection. We also thank Professor Adrian Esterman, Professor of Biostatistics from the University of South Australia, for his valuable advice. We also acknowledge and appreciate support from the Ministry of Health of Singapore and Ng Teng Fong General Hospital for the first author’s participation in the study.
The authors confirm that no funding from third party has been received.
Conflicts of interest
There is no conflict of interest involved in the publication of the study findings.
- 15.American Geriatrics Society. Beers criteria update expert panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older. J Am Geriatr Soc. 2015;2015(63):2227–46.Google Scholar
- 19.Wolfe MM. Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders. In: Post TW (Ed), UpToDate, Waltham, MA. Accessed 02 Jul 2016. https://www.uptodate.com/contents/overview-and-comparison-of-the-proton-pump-inhibitors-for-the-treatment-of-acid-related-disorders?source=search_result&search=over%20view%20proton%20pump%20inhibitors&selectedTitle=1~150.
- 21.Australian Medicines Handbook 2016 (online). Adelaide: Australian medicines handbook Pty Ltd; 2016 January. http://amhonline.amh.net.au/.
- 22.Therapeutic Goods Administration. Database of adverse event notifications (DAEN). Canberra, Australia. http://apps.tga.gov.au/PROD/DAEN/daen-entry.aspx.